BioCentury
ARTICLE | Finance

Mining fungi

Why GV backed LifeMine's $55M series A

September 22, 2017 4:58 AM UTC

Through GV, LifeMine Therapeutics Inc. will have access to big data expertise as it builds out its fungal DNA mining capabilities.

LifeMine raised $55 million in a series A round on Sept. 18 led by existing investor WuXi Healthcare Ventures. New investors GV, Foresite Capital, Arch Venture Partners, Boyu Capital, Blue Pool Capital, MRL Ventures Fund and Alexandria Venture Investments also participated...

BCIQ Company Profiles

LifeMine Therapeutics Inc.